![]() |
Boyd Haley, from the University of Kentucky, has spent his lifetime studying Biochemistry. After 30 years, he has discovered a powerful anti-oxidant, anti-inflammatory and detoxifying agent that can literally double your own body’s glutathione levels which you produce to safely perform all of these described functions.
We are beginning to realize that so many of our most devastating diseases-Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS), and Autism are related to toxicity. Also cancer, COPD, emphysema and myriads of other tragic diseases are associated with inflammation as its mechanism of injury.
Dr. Haley’s new formula, OSR-1 (Antioxidant Stress Relief) can begin to reverse so many of these diseases and disorders and can do it in as short a time as 6 weeks to several months.
You know from your own work-ups here at the Center for Occupational and Environmental Medicine that most of us are loaded with some level of toxic pollutants. We are very concerned about the serious role these pollutants can play in our health.
The feedback I get from some of my medical colleagues using OSR is very exciting. I now feel that we should all do a therapeutic trial with OSR for a minimum of one to three months. The dose varies from one dose a day to four doses a day depending on your diagnosis. When 65% of patients with ALS and Parkinson’s are responding to anti-oxidant, anti-inflammatory and detoxification therapy I don’t know that we can afford to NOT recommend a three months trial for these neurological problems.
We have also seen very significant changes in children diagnosed with Autism who have undergone this same type of treatment. As OSR does not seem to have any significant adverse side effects, I feel its safety and efficacy render it a very useable therapeutic agent for more diseases and disorders.
Although it is an over the counter product, the manufacturer will only sell it at this time to physicians to dispense to their patients. This is also because it is in limited supply. The cost, depending on the dose is $120-$480 a month but the majority of patients will require only one dose a day. Under these circumstances it may be wise to treat initially only the above listed disorders and for no more than three months unless the response has been clearly significant.
If you have any of the above described diseases we will be happy to discuss this treatment protocol with you.
We would order this product ONLY after you request it because of its expense and limited supply.
– Allan Lieberman, M.D.